Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Operating Leases (2019 - 2026)

Gyre Therapeutics has reported Operating Leases over the past 7 years, most recently at $303000.0 for Q4 2025.

  • Quarterly Operating Leases fell 65.76% to $303000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $303000.0 through Dec 2025, down 65.76% year-over-year, with the annual reading at $303000.0 for FY2025, 65.76% down from the prior year.
  • Operating Leases was $303000.0 for Q4 2025 at Gyre Therapeutics, down from $539000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $1.3 million in Q2 2024 and troughed at $121000.0 in Q4 2022.
  • The 5-year median for Operating Leases is $660500.0 (2021), against an average of $642071.4.
  • Year-over-year, Operating Leases tumbled 70.34% in 2022 and then soared 345.71% in 2025.
  • A 5-year view of Operating Leases shows it stood at $408000.0 in 2021, then tumbled by 70.34% to $121000.0 in 2022, then soared by 64.46% to $199000.0 in 2023, then surged by 344.72% to $885000.0 in 2024, then plummeted by 65.76% to $303000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Operating Leases are $303000.0 (Q4 2025), $539000.0 (Q3 2025), and $771000.0 (Q2 2025).